Results 181 to 190 of about 246,656 (358)

Modulation of Metabotropic Glutamate Receptors as a Strategy to Improve the Efficacy and Safety of Ketamine as an Antidepressant. [PDF]

Cells
Pałucha-Poniewiera A.
europepmc   +1 more source

Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Schizophrenia is characterized by positive, negative, and cognitive symptoms. Current pharmacological treatments often fail to address cognitive deficits. In this review of clinical trials, we aim to identify studies that explore neurobiological (non‐psychological) strategies to address Cognitive Impairment Associated with ...
Bahareh Peyrovian, Lena Palaniyappan, Theodore T. Kolivakis, Howard C. Margolese   +3 more
wiley   +1 more source

Gestational valproic acid exposure enhances facial stimulation-evoked cerebellar mossy fiber-granule cell transmission via GluN2A subunit-containing NMDA receptor in offspring mice [PDF]

Yong‐Xue Yuan, Yang Liu, Jing Zhang, Yan-Hua Bing, Chao-Yue Chen, Guang-Gao Li, Chun‐Ping Chu, Ming-Ji Yin, De‐Lai Qiu   +8 more
openalex   +1 more source

Aging and Surface Expression of Hippocampal NMDA Receptors [PDF]

, 2002
Daniel A. Clayton, David R. Grosshans, Michael Browning   +2 more
openalex   +1 more source

Encefalitis Autoinmune Anti-Receptor NMDA Reporte de Caso Clínico y Revisión de Literatura [PDF]

, 2020
Fernando Salazar Reinoso, Filadelfo Saltos Mata, Julit Cevallos Plúas, Gioconda Romero Santana   +3 more
openalex   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

Glutamate Receptor Agonists as Triggers of Neurotoxicity: Decoding Pathways of Five Neurotoxins and Potential Therapeutic Targets. [PDF]

ACS Omega
Turcatel GA, Moura S.
europepmc   +1 more source

The Interaction between Intrathecal NMDA Receptor Antagonist and 5-HT₃Receptor Agonist in the Rat Formalin Test

, 2007
Dong Woo Han, Tae Dong Kweon, Jong Seok Lee, Young Chul Yoo, Youn-Woo Lee, SunChong Kim   +5 more
openalex   +2 more sources

Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias

Addiction, EarlyView.
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley   +1 more source

An atypical case of overlapped anti-NMDA-R and anti-GFAP encephalitis secondary to a teratoma of the fallopian tube: a case report. [PDF]

BMC Neurol
Rivera Sánchez M, Gallego de Largy CC, Martín Arroyo J, Polanco Fernández M, Fadrique Rojo C, Vilares Calvo S, Ceballos Medina A, Mora Ruiz-Moyano R, Obeso González T, Diego Cuevas A, Martínez-Hernández E, Hermana Ramírez S, Fernández-Torre JL, Ruiz Pérez E, González Quintanilla V, Ortega-Valín F, Rodriguez-Rodríguez E.   +16 more
europepmc   +1 more source